Page 3 - Bellevue Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bellevue group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bellevue Group Today - Breaking & Trending Today

Bellevue Group AG Buys 382,531 Shares of Arvinas, Inc. (NASDAQ:ARVN)

Bellevue Group AG boosted its stake in shares of Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 18.0% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,507,731 shares of the company’s stock after buying an additional 382,531 shares during the quarter. Arvinas […] ....

Leerink Partnrs , Stifel Nicolaus , Exchange Commission , Wells Fargo Company , Arvinas Inc , Charles Schwab Investment Management Inc , Hermes Inc , Barclays Plc , Swiss National Bank , Bellevue Group , Free Report , National Bank , Schwab Investment Management , Federated Hermes , Get Free Report , Arvinas Daily ,

Bellevue Group AG Increases Stake in Celldex Therapeutics, Inc. (NASDAQ:CLDX)

Bellevue Group AG boosted its stake in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 27.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 2,416,296 shares of the biopharmaceutical company’s stock after purchasing an additional 516,296 shares during the […] ....

New York , United States , Elizabeth Crowley , Richardm Wright , Swiss National Bank , Bellevue Group , Celldex Therapeutics Inc , Principal Financial Group Inc , Securities Exchange Commission , Celldex Therapeutics , York State Common Retirement Fund , Charles Schwab Investment Management Inc , Deutsche Bank , Celldex Therapeutics Company Profile , Exchange Commission , Cantor Fitzgerald , Free Report , Financial Group , National Bank , Schwab Investment Management , Therapeutics Trading Down , Get Free Report , Visit Holdingschannel , Celldex Therapeutics Daily ,

Bellevue Group AG Has $280.70 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bellevue Group AG increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 0.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 832,041 shares of the medical equipment provider’s stock after purchasing an additional 3,042 shares during the […] ....

United States , Piper Sandler , Fredrik Widman , Goldman Sachs Group , Jefferies Financial Group , Intuitive Surgical Inc , Portside Wealth Group , Intuitive Surgical Company Profile , Securities Exchange Commission , Provence Wealth Management Group , Sequoia Financial Advisors , Kades Cheifetz , Bellevue Group , Intuitive Surgical , Free Report , Wealth Management Group , Wealth Group , Financial Advisors , Director Alan , Get Free Report , Financial Group , Vinci Surgical System , Visit Holdingschannel , Intuitive Surgical Daily ,

Bellevue Group AG Cuts Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Bellevue Group AG decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 26.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 736,390 shares of the pharmaceutical company’s stock after selling 266,345 shares during the period. Vertex Pharmaceuticals […] ....

Reshma Kewalramani , Brucei Sachs , Piper Sandler , Canaccord Genuity Group , Telos Capital Management Inc , Cantor Fitzgerald , Quarter For Vertex Pharmaceuticals , Sherbrooke Park Advisers , Vertex Pharmaceuticals Stock , Insider Transactions At Vertex Pharmaceuticals , Vertex Pharmaceuticals , Securities Exchange Commission , Exchange Commission , News Ratings For Vertex Pharmaceuticals Daily , Investment Management , Vertex Pharmaceuticals Incorporated , Bellevue Group , Morgan Stanley , Wolfe Research , Vertex Pharmaceuticals Profile , Free Report , Park Advisers , Capital Management , Grey Street Capital , Street Capital , Director Bruce ,

Bellevue Group AG Has $95.75 Million Stock Position in MacroGenics, Inc. (NASDAQ:MGNX)

Bellevue Group AG raised its stake in MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 1.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,953,313 shares of the biopharmaceutical company’s stock after acquiring an additional 150,000 shares during the quarter. MacroGenics comprises approximately […] ....

United States , Jeffrey Stuart Peters , Stifel Nicolaus , Exchange Commission , Barclays Plc , Silverarc Capital Management , Principal Financial Group Inc , Bellevue Group , Massachusetts Financial Services Co , Macrogenics Inc , Free Report , Financial Group , Financial Services , Capital Management , Get Free Report , Stuart Peters , Macrogenics Daily ,